MCD
Clinical trials for MCD explained in plain language.
Never miss a new study
Get alerted when new MCD trials appear
Sign up with your email to follow new studies for MCD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could protect kidneys in autoimmune diseases
Disease control Recruiting nowThis study tests a drug called atacicept in 200 adults and teens with autoimmune kidney diseases like IgAN and FSGS. The goal is to see if it safely reduces protein in the urine and helps preserve kidney function. Participants must already be on standard treatments and weigh at l…
Matched conditions: MCD
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Personalized trial matching could revolutionize kidney care
Knowledge-focused Recruiting nowThis study helps people with certain kidney diseases (like nephrotic syndrome and FSGS) find clinical trials that might be a good fit for their specific condition. Researchers use advanced molecular testing to match each person's unique disease profile to targeted therapies being…
Matched conditions: MCD
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 17, 2026 04:01 UTC
-
New study aims to unlock mysteries of kidney disease return after transplant
Knowledge-focused Recruiting nowThis study is gathering information and biological samples from 300 people with FSGS or MCD who have had or will have a kidney transplant. Researchers want to learn why the disease sometimes comes back after transplant, which can lead to graft loss. The goal is to create a shared…
Matched conditions: MCD
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 17, 2026 04:00 UTC
-
New kidney drug SK-09 tested in humans for first time
Knowledge-focused Recruiting nowThis early-stage study tests the safety of a new oral drug called SK-09 in 72 healthy adults aged 18 to 55. It is the first time this drug is given to humans, and it aims to find a safe dose for future studies in patients with kidney diseases like FSGS and MCD. Participants recei…
Matched conditions: MCD
Phase: PHASE1 • Sponsor: Consun Pharmaceutical Group • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC